Stephen M. Schreibman
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 11
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
- Neurology top 10%
- Neuroblastoma Research and Treatments 4
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 5
-
- Cancer Genomics and Diagnostics 12
-
- Renal cell carcinoma treatment 3
- Co-authors
- Robert L. FineDavid R. FogelmanJohn A. ChabotWilliam H. ShermanBeth SchropeJohn AllendorfAnthony P. GulatiBenjamin A. Krantz
- Cited by
- OncologyNeurologyEpidemiology
- Journals
- Journal of Clinical Oncology (11 papers)The Journal of Urology (1 paper)The Oncologist (1 paper)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Stephen M. Schreibman
19 papers receiving 396 citations
Peers
Comparison fields: 5 of 41
- Oncology 330
- Neurology 183
- Epidemiology 254
- Cancer Research 74
- Genetics 36
Countries citing papers authored by Stephen M. Schreibman
This map shows the geographic impact of Stephen M. Schreibman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Schreibman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Schreibman more than expected).
Fields of papers citing papers by Stephen M. Schreibman
This network shows the impact of papers produced by Stephen M. Schreibman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Schreibman. The network helps show where Stephen M. Schreibman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen M. Schreibman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2022 | 5 | |
| 3 | 2014 | 2 | |
| 4 | 2013 | 186 | |
| 5 | 2013 | 2 | |
| 6 | 2013 | 2 | |
| 7 | 2012 | 6 | |
| 8 | 2009 | 11 | |
| 9 | 2007 | 71 | |
| 10 | 2007 | 5 | |
| 11 | 2006 | 1 | |
| 12 | 2005 | 3 | |
| 13 | 2005 | 50 | |
| 14 | 2004 | 16 | |
| 15 | 2004 | 11 | |
| 16 | 2004 | 2 | |
| 17 | 2004 | 2 | |
| 18 | 2004 | 3 | |
| 19 | 1974 | 27 |
About Stephen M. Schreibman
Stephen M. Schreibman is a scholar working on Cancer Research, Oncology and Neurology, having authored 19 papers that have together received 408 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (11 papers), Colorectal Cancer Treatments and Studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers), Neuroblastoma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Research Studies (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Oncology (330 citations), Neurology (183 citations) and Epidemiology (254 citations). Stephen M. Schreibman has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Robert L. Fine, David R. Fogelman, John A. Chabot, William H. Sherman, Beth Schrope, John Allendorf, Anthony P. Gulati, Benjamin A. Krantz, James A. Lee and Rebecca A. Moss. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.